Early-stages cutaneous melanoma are treated primarily with surgical resection; while advanced, invasive, malignant melanoma shows very little response to conventional chemotherapy and radiation therapy. new immunotherapeutic agents have been approved and tested as potentially highly efficient treatment for melanoma.